Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26274893)

Published in Oncotarget on September 08, 2015

Authors

Michael W Pickup1, Laura D Hover2, Yan Guo3,4, Agnieszka E Gorska4, Anna Chytil4, Sergey V Novitskiy4, Harold L Moses4, Philip Owens4

Author Affiliations

1: Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California at San Francisco, San Francisco, CA, USA.
2: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
3: Vanderbilt Ingram Cancer Center, Center for Quantitative Sciences, Nashville, TN, USA.
4: Department of Cancer Biology, Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.

Articles cited by this

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98

A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86

Bone: formation by autoinduction. Science (1965) 13.34

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 10.49

Bone morphogenetic proteins. Growth Factors (2004) 8.61

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat (2009) 7.91

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36

Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell (2011) 4.79

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res (2010) 4.61

Bone morphogenetic protein receptors and signal transduction. J Biochem (2009) 4.51

Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development. Development (2004) 3.46

Landscaping the cancer terrain. Science (1998) 2.93

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell (2012) 2.84

Generation of Bmpr/Alk3 conditional knockout mice. Genesis (2002) 2.71

Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol (2003) 2.65

Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res (2005) 2.63

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med (2011) 2.38

TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell (2012) 2.08

Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics (2006) 2.04

Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle. EMBO J (2000) 2.01

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene (2008) 1.59

Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J Cell Sci (2003) 1.45

BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res (2011) 1.23

Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis (2004) 1.22

Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer (2010) 1.22

BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice. Development (2004) 1.18

The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene (2011) 1.17

Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc Natl Acad Sci U S A (2011) 1.14

The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev (2010) 1.13

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat (2010) 1.13

TGF-beta and BMP7 interactions in tumour progression and bone metastasis. Clin Exp Metastasis (2007) 1.08

Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J Endocrinol (2002) 1.07

Epidermal Smad4 deletion results in aberrant wound healing. Am J Pathol (2009) 1.06

Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia (2010) 1.06

miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet (2014) 1.05

Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anticancer Drugs (1998) 1.04

Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde? Pathol Int (2013) 0.98

Advanced heat map and clustering analysis using heatmap3. Biomed Res Int (2014) 0.98

Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta (2000) 0.97

ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells. Cancer Res (2012) 0.94

Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals. J Biol Chem (2012) 0.93

Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One (2013) 0.93

Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res (2015) 0.90

Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene (2014) 0.90

TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. Cancer Res (2015) 0.90

Articles by these authors

Genomic Analysis of the BMP Family in Glioblastomas. Transl Oncogenomics (2015) 0.75